Reckitt Benckiser Group (OTCMKTS:RBGLY) Hits New 12-Month High – What’s Next?

Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) reached a new 52-week high during trading on Friday . The stock traded as high as $16.00 and last traded at $15.96, with a volume of 32537 shares traded. The stock had previously closed at $15.79.

Wall Street Analyst Weigh In

RBGLY has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Reckitt Benckiser Group in a research note on Monday, October 27th. Barclays upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Monday. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Thursday, October 23rd. Three equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Reckitt Benckiser Group presently has a consensus rating of “Buy”.

Reckitt Benckiser Group Stock Up 1.1%

The firm’s 50 day simple moving average is $15.49 and its 200-day simple moving average is $14.79. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.37 and a current ratio of 0.56.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.